Synthesis Side Stories: Capitalizing the Unintended Side‐Product
Helvetica Chimica Acta · 2026-05 · 109 (5)
DOI: 10.1002/hlca.202600001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helvetica Chimica Acta, online erschienen am 31.03.2026. Verfasst von Clara Massol‐Frieh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
This perspective discusses how unexpected side‐products in chemical reactions can lead to valuable synthetic methodologies. Through three case studies, it demonstrates how careful observation and mechanistic understanding can transform synthetic challenges into opportunities. The article also emphasizes that researchers should leverage AI and high‐throughput screening technologies, along with their associated data, to better investigate “failed” experiments and unexpected side‐products rather than dismissing them.
Zitieren
APA
Massol‐Frieh, C., & Vantourout, J. C. (2026). Synthesis Side Stories: Capitalizing the Unintended Side‐Product. Helvetica Chimica Acta, 109(5). https://doi.org/10.1002/hlca.202600001
Vancouver
Massol‐Frieh C, Vantourout JC. Synthesis Side Stories: Capitalizing the Unintended Side‐Product. Helvetica Chimica Acta. 2026;109(5). doi:10.1002/hlca.202600001
BibTeX
@article{MassolFrieh2026,
author = {Massol‐Frieh, Clara and Vantourout, Julien C.},
title = {Synthesis Side Stories: Capitalizing the Unintended Side‐Product},
journal = {Helvetica Chimica Acta},
year = {2026},
volume = {109},
number = {5},
doi = {10.1002/hlca.202600001}
}
EUVIMED